Renal Tubular Damage/dysfunction: Key to the Formation of Kidney Stones

Overview

Journal Urol Res

Specialty Urology

Date 2006 Jan 13

PMID 16404622

Citations 63

Authors

Saeed R Khan

Affiliations

Soon will be listed here.

Abstract

Supersaturation is the driving force behind crystal formation in the kidneys. It can, however, result only in the formation of crystals which can be harmlessly expelled. For stone formation, crystals must form in the kidneys and be retained there, which is indeed a rare occurrence. Crystalluria is common while stone formation is not. Only pathological changes in the kidneys including renal injury and dysfunction can accomplish crystal retention. Lethal epithelial cellular injury promotes crystal nucleation, aggregation and retention. Sub-lethal injury or dysfunctional cells may produce ineffective crystallization modulators and localized areas of supersaturation in the interstitium. The former will affect crystallization in the urine while the latter may cause precipitation in the interstitium and development of Randall's plaques.

Citing Articles

An analysis of the burden of urolithiasis: differences between the global, China, India and the United States, with projections through 2050.

Han S, Zhao S, Zhong R, Liu H, Liu L, Yan Y Urolithiasis. 2025; 53(1):32.

PMID: 39954073 DOI: 10.1007/s00240-025-01695-3.

Calcium sensing receptor regulate claudin-14 via PKA-STAT3 pathway in rat model of nephrolithiasis.

Luo P, Chen T, Zheng L, Zou J, Zou J, Li W Front Pharmacol. 2024; 15:1477122.

PMID: 39697555 PMC: 11652147. DOI: 10.3389/fphar.2024.1477122.

The impact of crystal phase transition on the hardness and structure of kidney stones.

Michibata U, Maruyama M, Tanaka Y, Yoshimura M, Yoshikawa H, Takano K Urolithiasis. 2024; 52(1):57.

PMID: 38563829 PMC: 10987347. DOI: 10.1007/s00240-024-01556-5.

Associations between smoke exposure and kidney stones: results from the NHANES (2007-2018) and Mendelian randomization analysis.

Huang Y, Wang H, Xu C, Zhou F, Su H, Zhang Y Front Med (Lausanne). 2023; 10:1218051.

PMID: 37636579 PMC: 10450509. DOI: 10.3389/fmed.2023.1218051.

The rs223114 polymorphism and the risk of nephrolithiasis: A case-control study from the Taiwan biobank.

Lin C, Chen I, Chen Y, Lin Y, Chang J, Wang T Front Endocrinol (Lausanne). 2023; 14:1074012.

PMID: 36967798 PMC: 10036833. DOI: 10.3389/fendo.2023.1074012.

References

Khan S, Cockrell C, Finlayson B, HACKETT R . Crystal retention by injured urothelium of the rat urinary bladder. J Urol. 1984; 132(1):153-7. DOI: 10.1016/s0022-5347(17)49509-7. View

Khan S, Shevock P, HACKETT R . Membrane-associated crystallization of calcium oxalate in vitro. Calcif Tissue Int. 1990; 46(2):116-20. DOI: 10.1007/BF02556095. View

Huang H, Ma M, Chen C, Chen J . Lipid peroxidation and its correlations with urinary levels of oxalate, citric acid, and osteopontin in patients with renal calcium oxalate stones. Urology. 2003; 62(6):1123-8. DOI: 10.1016/s0090-4295(03)00764-7. View

Kok D, Khan S . Calcium oxalate nephrolithiasis, a free or fixed particle disease. Kidney Int. 1994; 46(3):847-54. DOI: 10.1038/ki.1994.341. View

Khan S, Shevock P, HACKETT R . Urinary enzymes and calcium oxalate urolithiasis. J Urol. 1989; 142(3):846-9. DOI: 10.1016/s0022-5347(17)38928-0. View

Sanders J, Goor H, Hanemaaijer R, Kallenberg C, Stegeman C . Renal expression of matrix metalloproteinases in human ANCA-associated glomerulonephritis. Nephrol Dial Transplant. 2004; 19(6):1412-9. DOI: 10.1093/ndt/gfh186. View

van Oostrom O, Velema E, Schoneveld A, de Vries J, de Bruin P, Seldenrijk C . Age-related changes in plaque composition: a study in patients suffering from carotid artery stenosis. Cardiovasc Pathol. 2005; 14(3):126-34. DOI: 10.1016/j.carpath.2005.03.002. View

Riese R, Mandel N, Wiessner J, Mandel G, Becker C, Kleinman J . Cell polarity and calcium oxalate crystal adherence to cultured collecting duct cells. Am J Physiol. 1992; 262(2 Pt 2):F177-84. DOI: 10.1152/ajprenal.1992.262.2.F177. View

Khan S . Calcium oxalate crystal interaction with renal tubular epithelium, mechanism of crystal adhesion and its impact on stone development. Urol Res. 1995; 23(2):71-9. DOI: 10.1007/BF00307936. View

10.

Khan S, Finlayson B, Hackett R . Renal papillary changes in patient with calcium oxalate lithiasis. Urology. 1984; 23(2):194-9. DOI: 10.1016/0090-4295(84)90021-9. View

11.

Hautmann R, Osswald H . Concentration profiles of calcium and oxalate in urine, tubular fluid and renal tissue--some theoretical considerations. J Urol. 1983; 129(2):433-6. DOI: 10.1016/s0022-5347(17)52133-3. View

12.

Khan S . Role of renal epithelial cells in the initiation of calcium oxalate stones. Nephron Exp Nephrol. 2004; 98(2):e55-60. DOI: 10.1159/000080257. View

13.

Robertson W, Peacock M . Calcium oxalate crystalluria and inhibitors of crystallization in recurrent renal stone-formers. Clin Sci. 1972; 43(4):499-506. DOI: 10.1042/cs0430499. View

14.

Khan S, Kok D . Modulators of urinary stone formation. Front Biosci. 2004; 9:1450-82. DOI: 10.2741/1347. View

15.

Wiessner J, HASEGAWA A, Hung L, Mandel N . Oxalate-induced exposure of phosphatidylserine on the surface of renal epithelial cells in culture. J Am Soc Nephrol. 1999; 10 Suppl 14:S441-5. View

16.

Finlayson B, Reid F . The expectation of free and fixed particles in urinary stone disease. Invest Urol. 1978; 15(6):442-8. View

17.

Weller R, Nester B, Cooke S . Calcification in the human renal papilla: an electron-microscope study. J Pathol. 1972; 107(3):211-6. DOI: 10.1002/path.1711070308. View

18.

Umekawa T, Chegini N, Khan S . Oxalate ions and calcium oxalate crystals stimulate MCP-1 expression by renal epithelial cells. Kidney Int. 2002; 61(1):105-12. DOI: 10.1046/j.1523-1755.2002.00106.x. View

19.

Lieske J, Deganello S . Nucleation, adhesion, and internalization of calcium-containing urinary crystals by renal cells. J Am Soc Nephrol. 1999; 10 Suppl 14:S422-9. View

20.

Umekawa T, Chegini N, Khan S . Increased expression of monocyte chemoattractant protein-1 (MCP-1) by renal epithelial cells in culture on exposure to calcium oxalate, phosphate and uric acid crystals. Nephrol Dial Transplant. 2003; 18(4):664-9. DOI: 10.1093/ndt/gfg140. View